Research ArticleCancer

Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs

See allHide authors and affiliations

Science Translational Medicine  30 Jan 2019:
Vol. 11, Issue 477, eaat9143
DOI: 10.1126/scitranslmed.aat9143

Article Information

vol. 11 no. 477

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 18, 2018
  • Resubmitted August 31, 2018
  • Accepted for publication January 8, 2019
  • .

Author Information

  1. Susannah L. Hewitt*,
  2. Ailin Bai*,
  3. Dyane Bailey,
  4. Kana Ichikawa,
  5. John Zielinski,
  6. Russell Karp,
  7. Ameya Apte,
  8. Kristen Arnold,
  9. Sima J. Zacharek,
  10. Maria S. Iliou,
  11. Khushbu Bhatt,
  12. Maija Garnaas,
  13. Faith Musenge,
  14. Ashley Davis,
  15. Nikhil Khatwani,
  16. Stephen V. Su,
  17. Graham MacLean,
  18. Samuel J. Farlow,
  19. Kristine Burke and
  20. Joshua P. Frederick
  1. Moderna Inc., 200 Technology Square, Cambridge, MA 02139, USA.
  1. Corresponding author. Email: joshua.frederick{at}modernatx.com
  • * These authors contributed equally to this work as first authors.

Altmetric

Article usage

Article usage: January 2019 to November 2019

AbstractFullPdf
Jan 20193077795401
Feb 20193473918618
Mar 2019401344194
Apr 2019279265143
May 2019227185107
Jun 201930417581
Jul 201915121893
Aug 201911211973
Sep 201910812058
Oct 20191488958
Nov 20198913745